1. Home
  2. CV

as 07-18-2025 3:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

NYSE

CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.

Founded: 2005 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 194.2M IPO Year: 2025
Target Price: N/A AVG Volume (30 days): 1.0M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.02 EPS Growth: N/A
52 Week Low/High: $3.49 - $5.72 Next Earning Date: 01-01-0001
Revenue: $12,044,000 Revenue Growth: 20.54%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest CAPSOVISION INC News

CV Breaking Stock News: Dive into CV Ticker-Specific Updates for Smart Investing

All CV News

Share on Social Networks: